2 research outputs found
Drugs That Interrupt the Renin-Angiotensin System Should Be Among the Preferred Initial Drugs to Treat Hypertension
- Author
- Aberg
- ALLHAT officers and coordinators for the ALLHAT Collaborative Research Group
- Baruch
- Baruch
- Biollaz
- Black
- Bloom
- Brenner
- Brown
- Chobanian
- Chrysant
- Cifkova
- Cohn J Tognoni G, and Val-HeFT Investigators
- Conlin
- Conlin
- Cottone
- Crozier
- Dahloff
- Dahloft
- Dickstein K Kjekshus J, and the OPTIMAAL Steering Committee of the OPTIMAAL Study Group
- Dzau
- Franse
- Gavras
- Gavras I Gavras H, and The Eprosartan Study Group
- Giatras
- Goldberg
- Gottdiener
- Gottlieb
- Granger
- Gremmler
- Grimm
- Hansson
- Hansson
- Heras
- Hjalmarson
- Kaplan
- Kaplan
- Kochar
- Konstam
- Lang
- Lebrillant
- Levy
- Lewis
- Lewis
- MacKay
- Makris
- Maschio
- McInnes
- McKelvie
- Moore
- Moore
- Moser
- Moser
- Neldam
- Oparil
- Paran
- Parker
- Peters
- Phelps
- Pitt
- Pitt
- Plat
- Reams
- Rutherford
- Schiffrin
- Schiffrin
- Sebastian
- Soffer
- Svensson
- The Heart Outcomes Prevention Evaluation Study Investigators
- Tonkon
- Torp-Pedersen
- Toto
- US Renal Data System
- Vasan
- Veterans Administration Study Group
- Veterans Administrative Cooperative Study Group
- Vidal
- Waeber
- Yoshimuira
- Publication venue
- 'Wiley'
- Publication date
- Field of study
No full textGender differences in the effects of cardiovascular drugs
- Author
- American College of Cardiology/American Heart Association Task Force on Practice Guidelines
- American Heart Association Statistics Committee and Stroke Statistics Subcommittee
- Antithrombotic Trialists' Collaboration
- APPROVE Investigators
- ARISTOTLE Committees and Investigators
- ASSENT-2 Investigators. Assessment of the Safety and Efficacy of a New Thrombolytic
- ATLAS ACS 2–TIMI 51 Investigators
- Authors/Task Force Members
- AVERROES Steering Committee and Investigators
- BEAUTIFUL Investigators
- Beta-Blockers in Heart Failure Collaborative Group
- Canadian Acute Coronary Syndrome Registry I and II Investigators
- Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group
- Carvedilol Prospective Randomized Cumulative Survival Study Group
- CHAMPION PHOENIX Investigators
- CHARM Investigators and Committees
- Cholesterol Treatment Trialists' (CTT) Collaboration
- Collaboration Antithrombotic Trialists
- CRUSADE Investigators
- ENGAGE AF-TIMI 48 Investigators
- Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
- ESPRIT Investigators
- ESSENCE (Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events) and TIMI (Thrombolysis in Myocardial Infarction) 11B Investigators
- EUGenMed Cardiovascular Clinical Study Group
- European Atherosclerosis Society Consensus Panel
- Fibrinolytic Therapy Trialists' (FTT) Collaborative Group
- Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators
- For the ACE inhibitor myocardial infarction collaborative group
- For the Amlodipine Cardiovascular Community Trial Study Group
- For the GUSTO-I Investigators
- For the HOT Study Group
- For the SWORD Investigators
- Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group
- Gruppo Italiano per lo Studio Della Streptochinasi nell'Infarto Miocardico (GISSI)
- Gusto V Investigators
- INITIATIVE Investigators
- Institute of Medicine (US) Committee on Women's Health Research Board on Population Health
- INTERHEART Study Investigators
- ISCOAT Study Group (Italian Study on Complications of Oral Anticoagulant Therapy)
- ISIS-2 (Second International Study of Infarct Survival) Collaborative Group
- LIFE Study Group
- National Institutes of Health
- OASIS-6 Investigators
- OASIS-6 Trial Group
- Office of Extramural Research NIH
- OPTIMAAL Steering Committee of the OPTIMAAL Study Group
- PARADIGM-HF Committees Investigators
- PARADIGM-HF Investigators and Committees
- PLATO Investigators
- PLATO study group
- RE-LY Steering Committee and Investigators
- REMIT Investigators
- REPLACE-2 Investigators
- REPLACE-2 Investigators
- ROCKET AF Investigators
- SCAAR Study Group
- SHIFT Investigators
- SYNERGY Trial Investigators
- The GUSTO Investigators
- The Heart Outcomes Prevention Evaluation Study Investigators
- The MERIT-HF Study Group
- The SOLVD Investigattors
- TIMI 11A Investigators
- TRITON-TIMI 38 Investigators
- US General Accounting Office (GAO)
- VALIANT Investigators
- Valsartan Heart Failure Trial Investigators
- Valsartan in Acute Myocardial Infarction Trial Investigators
- VALUE Trial Group
- Women's Health Initiative Investigators
- Working Group on Thrombosis of the Italian Society of Cardiology
- Writing Group for the Women's Health Initiative Investigators
- Publication venue
- 'Oxford University Press (OUP)'
- Publication date
- Field of study
No full text
